Predicting response to neoadjuvant chemotherapy in patients with oesophageal adenocarcinoma.
Rebecca K BottGincy GeorgeRicardo McEwenJanine ZylstraWilliam R C KnightCara R BakerMark KellyNyree GriffinNaami McAddyNick MaiseyMieke Van HemelrijckJames A GossageJesper LagergrenAndrew R DaviesPublished in: Acta oncologica (Stockholm, Sweden) (2021)
This study has highlighted the potential for using pre-defined factors to identify those patients who have responded to neoadjuvant chemotherapy, prior to surgical resection, potentially facilitating a more individualised therapeutic approach.